National Guideline Clearinghouse | The prophylactic use of filgrastim in patients with hematological malignancies.

Guideline Title
Cancer Care Ontario Web site [CCO]
The prophylactic use of filgrastim in patients with hematological malignancies.

Bibliographic Source(s)
Kouroukis CT, Haynes AE. The prophylactic use of filgrastim in patients with hematological malignancies. Toronto (ON): Cancer Care Ontario (CCO); 2009 Sep 23. 19 p. (CED-CCO special advice report; no. 14-1). [29 references]

Guideline Status
This is the current release of the guideline.

The SPECIAL ADVICE report over time will expand to contain new information emerging from their reviewing and updating activities.

Please visit the Cancer Care Ontario Web site [CCO] for details on any new evidence that has emerged and implications to the guidelines.

full-text:
National Guideline Clearinghouse | The prophylactic use of filgrastim in patients with hematological malignancies.